Arvee Laboratories Intrinsic Value
ARVEE Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹78.51 | ₹62.81 - ₹94.21 | -70.0% | EPS: ₹0.40, Sector P/E: 12x |
| Book Value Method | asset | ₹52.34 | ₹47.11 - ₹57.57 | -80.0% | Book Value/Share: ₹28.18, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹78.51 | ₹70.66 - ₹86.36 | -70.0% | Revenue/Share: ₹24.55, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹104.68 | ₹94.21 - ₹115.15 | -60.0% | EBITDA: ₹2.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹104.68 | ₹83.74 - ₹125.62 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹78.51 | ₹70.66 - ₹86.36 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹78.51 | ₹70.66 - ₹86.36 | -70.0% | Revenue Growth: -9.9%, Adj P/E: 8.0x |
| Graham Defensive Method | conservative | ₹78.51 | ₹70.66 - ₹86.36 | -70.0% | EPS: ₹0.40, BVPS: ₹28.18 |
Want to compare with current market value? Check ARVEE share price latest .
Valuation Comparison Chart
ARVEE Intrinsic Value Analysis
What is the intrinsic value of ARVEE?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Arvee Laboratories (ARVEE) is ₹78.51 (median value). With the current market price of ₹261.71, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹52.34 to ₹104.68, indicating ₹52.34 - ₹104.68.
Is ARVEE undervalued or overvalued?
Based on our multi-method analysis, Arvee Laboratories (ARVEE) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 11.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.23 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 3.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.71x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Arvee Laboratories
Additional stock information and data for ARVEE
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹4 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2020 | ₹10 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |